Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| pericyte | 18 studies | 38% ± 15% | |
| smooth muscle cell | 16 studies | 27% ± 10% | |
| endothelial cell | 9 studies | 29% ± 10% | |
| glutamatergic neuron | 9 studies | 51% ± 23% | |
| GABAergic neuron | 7 studies | 35% ± 18% | |
| interneuron | 4 studies | 30% ± 9% | |
| neuron | 3 studies | 28% ± 4% | |
| adipocyte | 3 studies | 35% ± 9% | |
| connective tissue cell | 3 studies | 29% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 8 studies | 36% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 99% | 8220.22 | 179 / 180 | 96% | 58.52 | 412 / 430 |
| esophagus | 88% | 4044.77 | 1267 / 1445 | 96% | 24.65 | 175 / 183 |
| breast | 93% | 5165.90 | 427 / 459 | 89% | 16.96 | 995 / 1118 |
| prostate | 85% | 4846.73 | 209 / 245 | 90% | 17.41 | 452 / 502 |
| thymus | 81% | 2779.61 | 530 / 653 | 89% | 57.12 | 539 / 605 |
| lung | 78% | 2635.69 | 450 / 578 | 90% | 22.21 | 1040 / 1155 |
| uterus | 92% | 4327.19 | 156 / 170 | 75% | 22.70 | 342 / 459 |
| bladder | 76% | 2999.19 | 16 / 21 | 83% | 14.15 | 417 / 504 |
| brain | 49% | 1707.59 | 1289 / 2642 | 86% | 20.23 | 605 / 705 |
| stomach | 34% | 1139.37 | 122 / 359 | 94% | 18.36 | 269 / 286 |
| intestine | 34% | 996.59 | 332 / 966 | 88% | 14.03 | 466 / 527 |
| skin | 72% | 5825.82 | 1307 / 1809 | 45% | 10.17 | 213 / 472 |
| blood vessel | 100% | 30523.42 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.17 | 1 / 1 |
| pancreas | 2% | 37.16 | 6 / 328 | 97% | 20.77 | 172 / 178 |
| adipose | 98% | 8519.86 | 1185 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 98% | 65.73 | 78 / 80 |
| liver | 28% | 673.27 | 64 / 226 | 63% | 9.80 | 255 / 406 |
| kidney | 24% | 771.91 | 21 / 89 | 66% | 16.07 | 598 / 901 |
| spleen | 89% | 3369.38 | 215 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 80% | 16.26 | 36 / 45 |
| adrenal gland | 7% | 151.69 | 18 / 258 | 69% | 15.52 | 158 / 230 |
| muscle | 53% | 2079.15 | 424 / 803 | 0% | 0 | 0 / 0 |
| heart | 40% | 1067.75 | 346 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 31% | 2.51 | 9 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0045833 | Biological process | negative regulation of lipid metabolic process |
| GO_0007165 | Biological process | signal transduction |
| GO_0051055 | Biological process | negative regulation of lipid biosynthetic process |
| GO_0046889 | Biological process | positive regulation of lipid biosynthetic process |
| GO_0008610 | Biological process | lipid biosynthetic process |
| GO_0010804 | Biological process | negative regulation of tumor necrosis factor-mediated signaling pathway |
| GO_0045600 | Biological process | positive regulation of fat cell differentiation |
| GO_0010629 | Biological process | negative regulation of gene expression |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005576 | Cellular component | extracellular region |
| Gene name | CCDC3 |
| Protein name | Coiled-coil domain-containing protein 3 (Fat/vessel-derived secretory protein) (Favine) |
| Synonyms | |
| Description | FUNCTION: Negatively regulates TNF-alpha-induced pro-inflammatory response in endothelial cells (ECs) via inhibition of TNF-alpha-induced NF-kappaB activation in ECs . Positively regulates lipid accumulation in adipose cells (By similarity). . |
| Accessions | ENST00000378839.1 [Q9BQI4-2] ENST00000378825.5 [Q9BQI4-1] Q9BQI4 |
